BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8537121)

  • 1. Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes.
    Singal DP; Qiu X
    Immunogenetics; 1996; 43(1-2):50-6. PubMed ID: 8537121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the Y box controls level of cytokine-mediated expression of HLA-DRB1 genes.
    Sindwani S; Singal DP
    Tissue Antigens; 2001 Nov; 58(5):315-23. PubMed ID: 11844142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.
    Emery P; Mach B; Reith W
    Hum Immunol; 1993 Oct; 38(2):137-47. PubMed ID: 8106268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transcriptional activities of HLA-DR genes in the various haplotypes.
    Louis P; Vincent R; Cavadore P; Clot J; Eliaou JF
    J Immunol; 1994 Dec; 153(11):5059-67. PubMed ID: 7963565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes.
    Andersen LC; Beaty JS; Nettles JW; Seyfried CE; Nepom GT; Nepoom BS
    J Exp Med; 1991 Jan; 173(1):181-92. PubMed ID: 1985121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
    Ono SJ; Song Z
    J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution.
    Louis P; Eliaou JF; Kerlan-Candon S; Pinet V; Vincent R; Clot J
    Immunogenetics; 1993; 38(1):21-6. PubMed ID: 8462990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction.
    Vincent R; Louis P; Gongora C; Papa I; Clot J; Eliaou JF
    J Immunol; 1996 Jan; 156(2):603-10. PubMed ID: 8543811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the promoter region of HLA-DRB genes.
    Perfetto C; Zacheis M; McDaid D; Meador JW; Schwartz BD
    Hum Immunol; 1993 Jan; 36(1):27-33. PubMed ID: 8458736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II box consensus sequences in the HLA-DR alpha gene: transcriptional function and interaction with nuclear proteins.
    Sherman PA; Basta PV; Moore TL; Brown AM; Ting JP
    Mol Cell Biol; 1989 Jan; 9(1):50-6. PubMed ID: 2538724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors.
    Mischiati C; Feriotto G; Bianchi N; Rutigliano C; Giacomini P; Gambari R
    Biochimie; 1999 Mar; 81(3):219-28. PubMed ID: 10385003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic polymorphism in the upstream regulatory region of HLA-DRB genes: functional role of conserved consensus motifs.
    Qiu X; Singal DP
    Transplant Proc; 1995 Feb; 27(1):682-3. PubMed ID: 7879144
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of the sequence variations of the HLA-DR promoters derived from human melanoma cell lines on nuclear protein binding and promoter activity.
    Lee TJ; Kim SJ; Park JH
    Yonsei Med J; 2000 Oct; 41(5):593-9. PubMed ID: 11079619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes.
    Singal DP; Qiu X
    Mol Immunol; 1994 Oct; 31(14):1117-20. PubMed ID: 7523867
    [No Abstract]   [Full Text] [Related]  

  • 19. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
    Rousseau P; Paul P; O'Brien M; Dausset J; Carosella ED; Moreau P
    Hum Immunol; 2000 Nov; 61(11):1132-7. PubMed ID: 11137218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
    Panek RB; Moses H; Ting JP; Benveniste EN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.